Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy

Consolidation Chemotherapy for Locally Advanced Mid or Low Rectal Cancer After Neoadjuvant Concurrent Chemoradiotherapy is a phase 3, randomised interventional study registered as NCT02843191 by Kyung Hee University Hospital at Gangdong, with a registry enrolment figure of 358 participants, started 2016-12-07 and due to reach its primary completion in 2023-07-15. Interventions recorded: Chemotherapy. Conditions listed: Rectal Cancer. Primary outcome: Pathologic complete response; Disease-free survival. Colorectal eligibility wording from the registry: "Histologically confirmed adenocarcinoma of mid or low rectum". Sites: South Korea. No results are recorded here; the registry entry is the source.